PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Emam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tehran, Iran.\', \'Department of Infectious Diseases, Emam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Pulmonary and Critical Care Medicine, Emam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Orthopedic Surgery, Emam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Radiology, Emam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.\', \'Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.\', \'PersisGen Par Company, Alborz, Iran.\', \'Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/iid3.563
?:hasPublicationType
?:journal
  • Immunity, inflammation and disease
is ?:pmid of
?:pmid
?:pmid
  • 34762351
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • 3
is ?:relation_isRelatedTo_publication of
?:title
  • A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34762351>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34762351>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all